February 5, 2013 Program

Posted Under:

Andres Liivak, Co-Chair, Life Sciences Industry Group at Kaye Scholer LLP moderated a panel discussion on

Why, How and When: Private Foundations work with proof of concept, early and late stage companies and fund their research and drug development.

Members of the panel:
  • Page Snow, Chief Philanthropic Officer at Foundation Source
  • Diane Goetz, Director of patient and professional advocacy, PTC Therapeutics
  • Robert Lorette, Senior Vice President, Business Development of TB Alliance